STOCK TITAN

GENELUX (NASDAQ: GNLX) director granted RSUs and options in new equity awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GENELUX Corp director John W. Smither reported equity awards consisting of restricted stock units and stock options. He received 28,409 shares of Common Stock as a grant, bringing his directly held Common Stock to 103,403 shares following the award.

Smither was also granted stock options covering 31,566 shares of Common Stock at an exercise price of $3.03 per share, expiring on June 15, 2036. Both the restricted stock units and the options vest upon the earlier of the one-year anniversary of the grant date or the company’s next annual meeting of stockholders.

Positive

  • None.

Negative

  • None.
Insider Smither John W
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 31,566 $0.00 --
Grant/Award Common Stock 28,409 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 31,566 shares (Direct, null); Common Stock — 103,403 shares (Direct, null)
Footnotes (1)
  1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
RSUs granted 28,409 shares Restricted stock units granted to director on June 16, 2026
Common stock holdings after grant 103,403 shares Directly held GENELUX Common Stock following RSU award
Stock options granted 31,566 options Options on Common Stock granted on June 16, 2026
Option exercise price $3.03 per share Exercise price for 31,566 stock options
Option expiration June 15, 2036 Expiration date of newly granted stock options
Vesting trigger Earlier of 1-year or next annual meeting Applies to both RSUs and stock options
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2022 Equity Incentive Plan financial
"RSUs granted pursuant to the Issuer's 2022 Equity Incentive Plan."
stock option financial
"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "3.0300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smither John W

(Last)(First)(Middle)
C/O GENELUX CORPORATION
2625 TOWNSGATE ROAD, SUITE 230

(Street)
WESTLAKE VILLAGE CALIFORNIA 91361

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GENELUX Corp [ GNLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/16/2026A(1)28,409A$0103,403D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.0306/16/2026A31,566 (2)06/15/2036Common stock31,566$031,566D
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
2. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
/s/ Thomas Zindrick, Attorney-in-Fact06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did GENELUX (GNLX) director John W. Smither report?

John W. Smither reported equity awards, including 28,409 shares of Common Stock and stock options on 31,566 shares. These transactions reflect compensation grants rather than open-market buying or selling of GENELUX stock, and increase his reported equity-based holdings in the company.

How many GENELUX (GNLX) shares does John W. Smither hold after these awards?

After the latest grant, John W. Smither directly holds 103,403 shares of GENELUX Common Stock. This figure reflects his position following receipt of 28,409 restricted stock units that convert into shares, as reported in the recent Form 4 insider filing.

What are the terms of John W. Smither’s new GENELUX (GNLX) stock options?

Smither received stock options on 31,566 GENELUX shares with an exercise price of $3.03 per share. These options expire on June 15, 2036 and will vest based on time or the next annual meeting, as detailed in the equity award disclosure.

When do John W. Smither’s GENELUX (GNLX) restricted stock units vest?

The restricted stock units vest upon the earlier of the one-year anniversary of the grant date or GENELUX’s next annual meeting of stockholders. Upon vesting, each RSU converts into one share of Common Stock, subject to the terms of the company’s 2022 Equity Incentive Plan.

Are John W. Smither’s recent GENELUX (GNLX) transactions market purchases or compensation grants?

The reported transactions are compensation-related grants, not market trades. The Form 4 identifies them with code A as a grant or award, covering 28,409 restricted stock units and stock options on 31,566 shares, both under GENELUX’s 2022 Equity Incentive Plan.

What plan governs John W. Smither’s new GENELUX (GNLX) equity awards?

The equity awards were granted under GENELUX’s 2022 Equity Incentive Plan. This plan allows the company to issue restricted stock units and stock options to directors and others, with specific vesting schedules tied to time or corporate events like the annual stockholder meeting.